{"nct_id":"NCT03224819","title":"Study of Emerfetamab (AMG 673) in Adults With Relapsed/Refractory Acute Myeloid Leukemia (AML)","status":"TERMINATED","status_verified_date":"2022-10","start_date":"2017-09-07","start_date_type":"ACTUAL","primary_completion_date":"2020-12-28","primary_completion_date_type":"ACTUAL","completion_date":"2020-12-28","completion_date_type":"ACTUAL","phases":["EARLY_PHASE1"],"tickers":["AMGN"]}